ESTRO37_ProgrammeBook

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

ELECTRONIC POSTERS

> Survey of Prostate Brachytherapy practice in the UK and Ireland 2014-2016 A.B. Mohamed Yoosuf (United Kingdom), G. Workman, M. Byrne, G. Corey, D.M. Mitchell, S. Jain > High dose rate brachytherapy delivered in two fractions within one day for prostate cancer N. Gorka (Spain), J.L. Lopez Guerra, E. Krumina, H. Marsiglia, M. Vila, A. Miró, A. Garcia, E. Gómez, I. Azinovic > A single centre experience of HDR brachytherapy as salvage treatment for relapsed prostate cancer E. Dugdale, F. Slevin (United Kingdom), S. Rodda, D. Bottomley, B. Carey, J. Smith, O. Hulson, E. Adiotomre, J. Mason, P. Bownes, A. Henry > Novel application of Gold-Nanoparticles in prostate LDR brachytherapy cancer treatment H. Safigholi (Islamic Republic of Iran) > Hypofractionated radiotherapy and single fraction brachtherapy boost in prostate cancer L. Larrea (Spain), E. López-Muñoz, P. Antonini, V. González-Vidal, M.C. Baños, J. Bea, M.A. García > Single fraction HDR brachytherapy in low-risk prostate cancer: a search for the best dose level L. Luthart (The Netherlands), I.K.K. Kolkman-Deurloo, W.M.H. Busser, S. Aluwini, M.E.M.C. Christianen > Edema adapted treatment plan in LDR prostate brachytherapy: beyond common inverse treatment planning K.A. Mountris (France), J. Bert, D. Visvikis > The first use of a biodegradable balloon spacer device for high dose rate prostate brachytherapy R. Alonzi (United Kingdom), P. Costa, L. Benjamin, C. Hardiman, G. Lowe, A. Fischer, R. Lad, H. Killen > Adverse events after HDR brachytherapy as monotherapy in localized prostate cancer S. Kariya (Japan), K. Kobayashi, I. Yamasaki, S. Ashida, K. Inoue, T. Yamagami

EP-2259

EP-2260

EP-2261

EP-2262

EP-2263

EP-2264

EP-2265

EP-2266

EP-2267

Programme and Exhibition Guide | POSTERS AND ELECTRONIC POSTERS

375